Aclaris Therapeutics
ACRS
ACRS
97 hedge funds and large institutions have $217M invested in Aclaris Therapeutics in 2024 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 15 closing their positions.
Holders
97
Holders Change
+17
Holders Change %
+21.25%
% of All Funds
1.29%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
34
Increased
25
Reduced
24
Closed
15
Calls
$850K
Puts
$372K
Net Calls
+$478K
Net Calls Change
+$417K
Top Buyers
Top Sellers
| 1 |
SCM
1
Stonepine Capital Management
Bend,
Oregon
|
$1.65M |
| 2 |
2
Millennium Management
New York
|
$4.86M |
| 3 |
TC
3
Trium Capital
London,
United Kingdom
|
$0 |
| 4 |
4
Renaissance Technologies
New York
|
$2.11M |
| 5 |
5
BlackRock
New York
|
$3.12M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
GCP
101
GSA Capital Partners
London,
United Kingdom
| – | -$293K | -255,032 | Closed |
|
|
ACM
102
ADAR1 Capital Management
Austin,
Texas
| – | -$104K | -90,000 | Closed |
|
|
BP
103
BBR Partners
New York
| – | -$69K | -60,000 | Closed |
|
104
Tudor Investment Corp
Stamford,
Connecticut
| – | -$38.2K | -33,183 | Closed |
|
|
SC
105
Shay Capital
New York
| – | -$31.1K | -27,000 | Closed |
|
|
AG
106
Algert Global
San Francisco,
California
| – | -$23K | -19,770 | Closed |
|
|
CUAMC
107
China Universal Asset Management Company
Shanghai,
China
| – | -$15.8K | -13,722 | Closed |
|
|
TSS
108
Two Sigma Securities
New York
| – | -$12.4K | -10,740 | Closed |
|
109
Mirae Asset Global Investments
Seoul,
South Korea
| – | -$3.02K | -2,580 | Closed |
|
|
AAP
110
Arax Advisory Partners
Denver,
Colorado
| – | -$1.88K | -1,632 | Closed |
|